CVS Caremark’s second-quarter earnings jumped 11 percent to top expectations, as specialty drug use helped fuel growth for the drugstore chain and pharmacy benefits manager.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
